Delivery Order SPE2DB24D3015-SPE2DB25FGANL
- Not listed
- The Defense Logistics Agency awarded a $6,638.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injections on September 8, 2025, with completion scheduled for September 9, 2025. This non-competitive delivery order represents a single pharmaceutical supply transaction executed through AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle valued through...
- The Defense Logistics Agency awarded a $3,947.26 delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injections on September 23, 2025, with completion scheduled for September 24, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $16,325.40 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors on August 26, 2025, with completion expected by August 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,029.53 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections (0.5 mL units). This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, represents a single transaction under AmerisourceBergen's broader pharmaceutical supply agreement with the federal government. The contract carries no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $45,099.00 for Mounjaro 5 mg/0.5 mL pen injections on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, consistent with...
- The Defense Logistics Agency awarded a $1,967.33 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on August 13, 2025, with completion targeted for August 14, 2025. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,057.94 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes treatment medication, consistent with AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a $1,632.54 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injectors on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed price contract represents a competitively awarded, non-set-aside procurement and is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,162.70 for Mounjaro 5 mg/0.5 mL pen injectors on August 20, 2025, with completion expected by August 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes. This delivery...
- The Defense Logistics Agency awarded a $2,777.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on September 8, 2025, with completion targeted for September 9, 2025. This delivery order, issued without a set-aside designation, represents a competitive award under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGANLDelivery Order
The Defense Logistics Agency awarded a $6,045.27 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injections on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication, consistent with AmerisourceBergen's established portfolio of pharmaceutical products supplied to federal military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's demonstrated capability to compete successfully for federal medical procurement and manage substantial contract volumes positions it as a critical vendor within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 8/13/25 |